Skip to main content Accessibility help
×
Home

Human fetal growth restriction: a cardiovascular journey through to adolescence

  • A. Sehgal (a1) (a2), M. R. Skilton (a3) and F. Crispi (a4)

Abstract

Intrauterine growth restriction has been noted to adversely impact morbidity and mortality in the neonatal period as well as cardiovascular well-being in adolescence and adulthood. Recent data based on a wide range of ultrasound parameters during fetal and neonatal life has noted early and persistent involvement of the cardiovascular system. Some of these measures are predictive of long-term morbidities. Assessment of vascular mechanics is a new and novel concept in this population, and opens up avenues for diagnosis, monitoring and evaluation of the likely effectiveness of interventions. Prevention of these adverse vascular and cardiac outcomes secondary to fetal growth restriction may be feasible and of clinical relevance. This review focuses on growth restriction in humans with respect to cardiovascular remodeling and dysfunction during fetal life, persistence of functional cardiac impairment during early childhood and adolescence, and possible preventive strategies.

Copyright

Corresponding author

*Address for correspondence: A. Sehgal, Neonatologist, Monash Newborn, Monash Children’s Hospital, Monash University, 246, Clayton Road, Clayton, Melbourne, VIC 3168, Australia. (Email Arvind.Sehgal@monash.edu)

Footnotes

Hide All

Arvind Sehgal wrote the first draft but all authors are equal first authors.

Footnotes

References

Hide All
1. Figueras, F, Gratacós, E. Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol. Fetal Diagn Ther. 2014; 36, 8698.
2. Alberry, M, Soothill, P. Management of fetal growth restriction. Arch Dis Child Fetal Neonatal Ed. 2007; 92, 6267.
3. Byrne, CD, Phillips, DI. Fetal origins of adult disease: epidemiology and mechanisms. J Clin Pathol. 2005; 3, 822828.
4. Gluckman, PD, Hanson, MA. Living the past: evolution, development, and patterns of disease. Science. 2004; 305, 17331736.
5. Cater, J, Gill, M. The follow-up study: medical aspects. In Low Birth Weight, a Medical Psychological and Social Study (eds. Illsley R, Mitchell RG), 1984; pp. 191205. John Wiley: Chichester.
6. Simpson, A, Mortimer, JG, Silva, PA, et al. Correlates of blood pressure in a cohort of Dunedin seven year old children. In Hypertension in the Young and Old (eds. Onesti G, Kim KE), 1981; pp. 153156. Grune and Stratton: New York, NY.
7. Barker, DJP, Osmond, C. Infant mortality, childhood nutrition and ischaemic heart disease in England and Wales. Lancet. 1986; 1, 10771081.
8. Barker, DJP, Osmond, C. Death rates from stroke in England and Wales predicted from past maternal mortality. Br Med J. 1987; 295, 8386.
9. Cruz-Lemini, M, Crispi, F, Valenzuela-Alcaraz, B, et al. A fetal cardiovascular score to predict infant hypertension and arterial remodeling in intrauterine growth restriction. Am J Obstet Gynecol. 2014; 210, 552.e1552.e22.
10. Sehgal, A, Doctor, T, Menahem, S. Cardiac function and arterial biophysical properties in small for gestational age infants: postnatal manifestations of fetal programming. J Pediatr. 2013; 163, 12961300.
11. Altin, H, Karaarslan, S, Karataş, Z, et al. Evaluation of cardiac functions in term small for gestational age newborns with mild growth retardation: a serial conventional and tissue Doppler imaging echocardiographic study. Early Hum Dev. 2012; 88, 757764.
12. Fouzas, S, Karatza, AA, Davlouros, PA, et al. Neonatal cardiac dysfunction in intrauterine growth restriction. Pediatr Res. 2014; 75, 651657.
13. Crispi, F, Figueras, F, Cruz-Lemini, M, et al. Cardiovascular programming in children born small for gestational age and relationship with prenatal signs of severity. Am J Obstet Gynecol. 2012; 207, 121e1121e9.
14. Bradley, TJ, Potts, JE, Lee, SK, et al. Early changes in the biophysical properties of the aorta in pre-adolescent children born small for gestational age. J Pediatr. 2010; 156, 388392.
15. Committee on Practice Bulletins Gynecology, American College of Obstetricians and Gynecologists. Intrauterine growth restriction. Clinical management guidelines for obstetrician-gynecologists. Int J Gynecol Obstet. 2001; 72, 8596.
16. Baschat, AA, Cosmi, E, Bilardo, CM, et al. Predictors of neonatal outcome in early-onset placental dysfunction. Obstet Gynecol. 2007; 109, 253261.
17. Baschat, AA. Neurodevelopment following fetal growth restriction and its relationship with antepartum parameters of placental dysfunction. Ultrasound Obstet Gynecol. 2011; 37, 501514.
18. Parra-Saavedra, M, Crovetto, F, Triunfo, S, et al. Placental findings in late-onset SGA births without Doppler signs of placental insufficiency. Placenta. 2013; 34, 11361141.
19. Crispi, F, Hernandez-Andrade, E, Pelsers, MM, et al. Cardiac dysfunction and cell damage across clinical stages of severity in growth-restricted fetuses. Am J Obstet Gynecol. 2008; 199, 254 e1254 e8.
20. Cruz-Lemini, M, Crispi, F, Valenzuela-Alcaraz, B, et al. Value of annular M-mode displacement versus tissue Doppler velocities to assess cardiac function in intrauterine growth restriction. Ultrasound Obstet Gynecol. 2013; 42, 175181.
21. Comas, M, Crispi, F, Cruz-Martinez, R, et al. Tissue Doppler echocardiographic markers of cardiac dysfunction in small-for-gestational age foetuses. Am J Obstet Gynecol. 2011; 205, 57e157e6.
22. Crispi, F, Bijnens, B, Figueras, F, et al. Fetal growth restriction results in remodelled and less efficient hearts in children. Circulation. 2010; 121, 24272436.
23. Cruz-Lemini, M, Bijnens, B, Valenzuela-Alcaraz, B, et al. Cardiac remodelling in utero in early- and late-onset intrauterine growth restriction. Ultrasound Obstet Gynecol. 2012; 40, 14.
24. Comas, M, Crispi, F, Cruz-Martinez, R, et al. Usefulness of myocardial tissue Doppler vs conventional echocardiography in the evaluation of cardiac dysfunction in early-onset intrauterine growth restriction. Am J Obstet Gynecol. 2010; 203, 45e145e7.
25. Bilardo, CM, Wolf, H, Stigter, RH, et al. Relationship between monitoring parameters and perinatal outcome in severe, early intrauterine growth restriction. Ultrasound Obstet Gynecol. 2004; 23, 119125.
26. Makikallio, K, Vuolteenaho, O, Jouppila, P, et al. Ultrasonographic and biochemical markers of human fetal cardiac dysfunction in placental insufficiency. Circulation. 2002; 105, 20582063.
27. Niewiadomska-Jarosik, K, Lipecka-Kidawska, E, Kowalska-Koprek, U, et al. Assessment of cardiac function in fetuses with intrauterine growth retardation using the Tei index. Med Wieku Rozwoj. 2005; 9, 153160.
28. Larsen, LU, Petersen, OB, Sloth, E, et al. Color Doppler myocardial imaging demonstrates reduced diastolic tissue velocity in growth retarded fetuses with flow redistribution. Eur J Obstet Gynecol Reprod Biol. 2011; 155, 140145.
29. Crispi, F, Bijnens, B, Sepulveda-Swatson, E, et al. Post-systolic shortening by myocardial deformation imaging as a sign of cardiac adaptation to pressure overload in fetal growth restriction. Circ Cardiovasc Imaging. 2014; 7, 781787.
30. Pérez-Cruz, M, Cruz-Lemini, M, Fernández, MT, et al. Fetal cardiac function in late-onset ‘intrauterine growth restriction’ versus ‘small-for-gestational age’ as defined by estimated fetal weight, cerebro-placental ratio and uterine artery Doppler. Ultrasound Obstet Gynecol. 2015; 46, 465471.
31. Cruz-Martinez, R, Figueras, F, Hernandez-Andrade, E, et al. Changes in myocardial performance index and aortic isthmus and ductus venosus Doppler in term, small-for-gestational age fetuses with normal umbilical artery pulsatility index. Ultrasound Obstet Gynecol. 2011; 38, 400405.
32. Chaiworapongsa, T, Espinoza, J, Yoshimatsu, J, et al. Subclinical myocardial injury in small-for-gestational-age neonates. J Matern Fetal Neonatal Med. 2002; 11, 385390.
33. Skilton, MK, Evans, N, Griffiths, KA, et al. Aortic wall thickness in newborns with intrauterine restriction. Lancet. 2005; 23, 14841486.
34. Rizzo, G, Capponi, A, Pietrolucci, ME, et al. The significance of visualising coronary blood flow in early onset severe growth restricted fetuses with reverse flow in the ductus venosus. J Matern Fetal Neonatal Med. 2009; 22, 547551.
35. Aburawi, EH, Malcus, P, Thuring, A, et al. Coronary flow in neonates with impaired intrauterine growth. J Am Soc Echocardiogr. 2012; 25, 313318.
36. Reller, MD, Morton, MJ, Giraud, GD, et al. Maximal myocardial blood flow is enhanced by chronic hypoxemia in late gestation fetal sheep. Am J Physiol. 1992; 263, H1327H1329.
37. Thornburg, KL, Reller, MD. Coronary flow regulation in the fetal sheep. Am J Physiol. 1999; 277, R1249R1260.
38. Sehgal, A, Doctor, T, Menahem, S. Cardiac function and arterial indices in infants born small for gestational age: analysis by speckle tracking. Acta Paediatr. 2014; 103, e49e54.
39. Koklu, E, Ozturk, MA, Kurtoglu, S, et al. Aortic intima-media thickness, serum IGF-I, IGFBP-3, and leptin levels in intrauterine growth-restricted newborns of healthy mothers. Pediatr Res. 2007; 62, 704709.
40. Zanardo, V, Fanelli, T, Weiner, G, et al. Intrauterine growth restriction is associated with persistent aortic wall thickening and glomerular proteinuria during infancy. Kidney Int. 2011; 80, 119123.
41. McGill, HC Jr, McMahan, CA, Herderick, EE, et al. Patho-biological determinants of atherosclerosis in youth research group. effect of coronary heart disease risk factors on atherosclerosis of selected regions of the aorta and right coronary artery. Arterioscler Thromb Vasc Biol. 2000; 20, 836845.
42. Litwin, M, Niemirska, A. Intima-media thickness measurements in children with cardiovascular risk factors. Pediatr Nephrol. 2008; 24, 707719.
43. Blacher, J, Safar, ME. Large artery stiffness, hypertension and cardiovascular risk in older patients. Cardiovasc Med. 2005; 2, 450455.
44. Tauzin, L, Rossi, P, Giusano, B, et al. Characteristics of arterial stiffness in very low birth weight premature infants. Pediatr Res. 2006; 60, 592596.
45. Norman, M, Martin, H. Preterm birth attenuates association between low birth weight and endothelial dysfunction. Circulation. 2003; 108, 9961001.
46. Martin, H, Gazelius, B, Norman, M. Impaired acetylcholine-induced vascular relaxation in low birth weight infants: implications for adult hypertension? Pediatr Res. 2000; 47, 457462.
47. Verburg, BO, Jaddoe, VW, Wladimiroff, JW, et al. Fetal hemodynamic adaptive changes related to intrauterine growth: the Generation R study. Circulation. 2008; 117, 649659.
48. Gardiner, H, Brodszki, J, Marsal, K. Ventriculo-vascular physiology of the growth restricted fetus. Ultrasound Obstet Gynecol. 2001; 18, 4753.
49. Tintu, A, Rouwet, E, Verlohren, S, et al. Hypoxia induces dilated cardiomyopathy in the chick embryo: mechanism, intervention, and long-term consequences. PLoS One. 2009; 4, e5155.
50. Tintu, AN, Noble, FA, Rouwet, EV. Hypoxia disturbs fetal hemodynamics and growth. Endothelium. 2007; 14, 353360.
51. Rouwet, EV, Tintu, AN, Schellings, MW, et al. Hypoxia induces aortic hypertrophic growth, left ventricular dysfunction, and sympathetic hyper-innervation of peripheral arteries in the chick embryo. Circulation. 2002; 105, 27912796.
52. Miles, KA, McDonnell, BJ, Maki-Petaja, KM, et al. The impact of birth weight on blood pressure and arterial stiffness in later life: the Enigma study. J Hypertens. 2011; 29, 23242331.
53. Dratva, J, Breton, CV, Hodis, HN, et al. Birth weight and carotid artery intima-media thickness. J Pediatr. 2013; 162, 906911.e2.
54. Skilton, MR, Pahkala, K, Viikari, JS, et al. The association of dietary alpha-linolenic acid with blood pressure and subclinical atherosclerosis in people born small for gestational age: the special turku coronary risk factor intervention project study. J Pediatr. 2015; 166, 12521257.
55. Skilton, MR, Ayer, JG, Harmer, JA, et al. Impaired fetal growth and arterial wall thickening. A randomized trial of omega-3 supplementation. Pediatrics. 2012; 129, e698.
56. Norman, M. Low birth weight and the developing vascular tree: a systematic review. Acta Paediatr. 2008; 97, 11651172.
57. Skilton, MR, Viikari, JS, Juonala, M, et al. Fetal growth and preterm birth influence cardiovascular risk factors and arterial health in young adults: the cardiovascular risk in young Finns study. Arterioscler Thromb Vasc Biol. 2011; 31, 29752981.
58. Napoli, C, Glass, CK, Witztum, JL, et al. Influence of maternal hypercholesterolaemia during pregnancy on progression of early atherosclerotic lesions in childhood: Fate of Early Lesions in Children (FELIC) study. Lancet. 1999; 354, 12341241.
59. Hietalampi, H, Pahkala, K, Jokinen, E, et al. Left ventricular mass and geometry in adolescence: early childhood determinants. Hypertension. 2012; 60, 12661272.
60. Kuh, D, Ben-Shlomo, Y. Should we intervene to improve fetal and infant growth?. In A Life Course Approach to Chronic Disease Epidemiology (eds. Kuh D, Ben Shlomo Y, Ezra S), 2004; pp. 399414. Oxford University Press: New York.
61. Godfrey, KM, Gluckman, PD, Hanson, MA. Developmental origins of metabolic disease: life course and intergenerational perspectives. Trends Endocrinol Metab. 2010; 21, 199205.
62. Yu, ZB, Han, SP, Zhu, GZ, et al. Birth weight and subsequent risk of obesity: a systematic review and meta-analysis. Obes Rev. 2011; 12, 525542.
63. Rodriguez-Lopez, M, Osorio, L, Acosta, R, et al. Influence of breastfeeding and postnatal nutrition on cardiovascular remodelling induced by fetal growth restriction. Pediatric Res. 2016; 79, 100106.
64. Stocks, T, Renders, CM, Bulk-Bunschoten, AM, et al. Body size and growth in 0-to 4-year-old children and the relation to body size in primary school age. Obes Rev. 2011; 12, 637652.
65. Skilton, MR, Marks, GB, Ayer, JG, et al. Weight gain in infancy and vascular risk factors in later childhood. Pediatrics. 2013; 131, e1821e1828.
66. Wen, LM, Baur, LA, Simpson, JM, et al. Effectiveness of home based early intervention on children’s BMI at age 2: randomised controlled trial. BMJ. 2012; 344, e3732.
67. Kramer, MS, Chalmers, B, Hodnett, ED, et al. Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus. JAMA. 2001; 285, 413420.
68. Skilton, MR, Raitakari, OT, Celermajer, DS. High intake of dietary long chain omega-3 fatty acids is associated with lower blood pressure in children born with low birth weight: NHANES 2003–2008. Hypertension. 2013; 61, 972976.
69. Mori, TA, Beilin, LJ. Omega-3 fatty acids and inflammation. Curr Atheroscler Rep. 2004; 6, 461467.
70. Labayen, I, Moreno, LA, Ruiz, JR, et al. Associations of birth weight with serum long chain polyunsaturated fatty acids in adolescents; the HELENA study. Atherosclerosis. 2011; 217, 286291.
71. Ozanne, SE, Martensz, ND, Petry, CJ, et al. Maternal low protein diet in rats programmes fatty acid desaturase activities in the offspring. Diabetologia. 1998; 41, 13371342.
72. Ornish, D, Brown, SE, Scherwitz, LW, et al. Can lifestyle changes reverse coronary heart disease? The lifestyle heart trial. Lancet. 1990; 336, 129133.
73. Estruch, R, Ros, E, Salas-Salvadó, J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013; 368, 12791290.
74. Giussani, DA, Camm, EJ, Niu, Y, et al. Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One. 2012; 7, e31017.
75. Kane, AD, Herrera, EA, Camm, EJ, et al. Vitamin C prevents intrauterine programming of in vivo cardiovascular dysfunction in the rat. Circ J. 2013; 77, 26042611.
76. Richter, HG, Camm, EJ, Modi, BN, et al. Ascorbate prevents placental oxidative stress and enhances birth weight in hypoxic pregnancy in rats. J Physiol. 2012; 15, 590, 13771387.
77. Cambonie, G, Comte, B, Yzydorczyk, C, et al. Antenatal antioxidant prevents adult hypertension, vascular dysfunction, and microvascular rarefaction associated with in utero exposure to a low-protein diet. Am J Physiol Regul Integr Comp Physiol. 2007; 292, R1236R1245.
78. Tare, M, Parkington, HC, Wallace, EM, et al. Maternal melatonin administration mitigates coronary stiffness and endothelial dysfunction, and improves heart resilience to insult in growth restricted lambs. J Physiol. 2014; 592, 26952709.
79. Itani, N, Skeffington, KL, Beck, C, et al. Melatonin rescues cardiovascular dysfunction during hypoxic development in the chick embryo. J Pineal Res. 2016; 60, 1626.
80. Skilton, MR, Mikkilä, V, Würtz, P, et al. Fetal growth, omega-3 (ω-3) fatty acids, and progression of subclinical atherosclerosis: preventing fetal origins of disease? The cardiovascular risk in young finns study. Am J Clin Nutr. 2013; 97, 5865.

Keywords

Related content

Powered by UNSILO

Human fetal growth restriction: a cardiovascular journey through to adolescence

  • A. Sehgal (a1) (a2), M. R. Skilton (a3) and F. Crispi (a4)

Metrics

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed.